Announcements A Joint Statement on Technical, legal, ethical and implementation concerns regarding Aarogya Setu and other apps introduced during COVID-19 in India by Jan Swasthya Abhiyan (JSA), Internet Freedom Foundation (IFF), Forum for Medical Ethics Society (FMES), and All India People’s Science Network (AIPSN)   |   Submission to the National Human Rights Commission (NHRC) on behalf of Hub5 (HEaL Institute, APU, Seher-CHSJ, and IAPH) – COPASAH on human rights issues confronted by ASHAS and ANMs during the Covid-19 pandemic | Aug 7, 2020   |   Letter to MMC by FMES, PUCL-MH, FAOW, and MFC urging to restore its order suspending licenses of two doctors accused of abetting the suicide of Dr Payal Tadvi

Ethical considerations in AIDS vaccine trials

Sanjay Mehendale


Abstract

The Joint United Nations Programme on HIV/AIDS (UNAIDS) estimated at the end of 1998 that around 33.4 million people were living with Human Immunodeficiency Virus (HIV) infection all over the world, over 90% of them in developing countries. However, in developing countries, promising newer therapeutic options for HIV/ AIDS are unaffordable, and prevention through behavioural change has not been successful due to illiteracy and low level of awareness. On the other hand, prophylactic vaccination has shown remarkable success in the control of many communicable diseases. Therefore global efforts are ongoing to develop vaccines to prevent infection among persons exposed to HIV (prophylactic) or prevent HIVinfected persons from progressing to AIDS (therapeutic vaccine).

Full Text

HTML PDF

Keywords

N/A

Refbacks

There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US